Evaluation of the Effects of Sequential Multiple- Dose Regimens of Levomilnacipran Er on Cardiac Repolarization in Healthy Subjects.

Trial Profile

Evaluation of the Effects of Sequential Multiple- Dose Regimens of Levomilnacipran Er on Cardiac Repolarization in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Apr 2014

At a glance

  • Drugs Levomilnacipran (Primary) ; Moxifloxacin
  • Indications Major depressive disorder; Stroke
  • Focus Adverse reactions
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 09 Apr 2014 New trial record
    • 22 Mar 2014 Results presented at the 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top